检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王坤[1] 赵沣凯 李彦林[1] 余洋[1] 高寰宇 肖渝[1] 李龙滕 闫祥甲 贾迪[1]
机构地区:[1]昆明医科大学第一附属医院运动医学科,650031 [2]山东省枣庄市枣矿集团公司中心医院,277800
出 处:《实用医学杂志》2015年第19期3133-3136,共4页The Journal of Practical Medicine
基 金:国家自然科学基金资助项目(编号:81460340);云南省创新团队项目(编号:2014HC018);云南省医学学科带头人培养项目(编号:D-201207)
摘 要:目的:明确T140体内靶向阻断SDF-1/CXCR4信号通路对基质细胞衍生因子-1(SDF-1)及基质金属蛋白酶(MMPs)的影响,探讨T140延缓软骨退变的作用。方法:健康9月龄雄性Hartley豚鼠36只,随机分成A组(实验组)、B组(实验对照组)、C组(空白对照组),每组12只。2、4、6、8、10、12周时,ELISA法测血清中SDF-1含量。12周时,RT-PCR法测关节软骨内基质金属蛋白酶(MMP-3、MMP-9、MMP-13)m RNA的表达。结果:A组血清中SDF-1含量逐渐降低,B、C组逐渐升高,同一时间比较,A组与B、C组有明显差异(P<0.05);A组MMP-3、9、13 m RNA的表达量低于B、C组,差异有统计学意义(P<0.05)。结论:T140靶向阻断SDF-1/CXCR4信号通路,减少血清中SDF-1的分泌并降低软骨内MMPs m RNA的表达量,从而减缓关节软骨的退变。Objective To explore the effect of T140 on SDF-1同 and MMPs levels through targeted blocking SDF-I/CXCR4 signaling pathway, and to investigate the function of T140 to prevent from cartilage degeneration. Methods Thirty-six 9-month-old male healthy Hartley guinea pigs were divided into three groups: experimental group(group A,n = 12),experimental control group(group B,n = 12) and blank control group (group C, n = 12). In the 2nd, 4th, 6th, 8th, 10th, 12th week, the levels of SDF-1 in serum were quantified with ELISA. In the 12th week, mRNA levels of MMP-3,MMP-9 and MMP-13 in articular cartilages were measured with RT-PCR. Results The serum levels of SDF-1 of the group A decreased gradually but increased in group B and C. Group A had a statistical significance compared with group B and C at the same time point(P 〈 0.05).The mRNA levels of MMPs in group A were lower than group B and C(P 〈 0.05). Conclusion T140 could block the SDF-1/CRCR4 signaling pathway and decrease the secretion of SDF-1 and mRNA expression levels of MMPs and reduce the cartilage degeneration.
关 键 词:T140 SDF-1/CRCR4信号通路 基质金属蛋白酶类 软骨退变
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222